Internalization of Coxsackievirus A9 Is Mediated by β2-Microglobulin, Dynamin, and Arf6 but Not by Caveolin-1 or ClathrinHEIKKILÄ, Outi; SUSI, Petri; TEVALUOTO, Tuire et al.Journal of virology. 2010, Vol 84, Num 7, pp 3666-3681, issn 0022-538X, 16 p.Article

Preliminary crystallographic analysis of coxsackievirus A9SMYTH, M; HALL, J; FRY, E et al.Journal of molecular biology. 1993, Vol 230, Num 2, pp 667-669, issn 0022-2836Article

Integrin αVβ6 is a high-affinity receptor for coxsackievirus A9HEIKKILÄ, Outi; SUSI, Petri; STANWAY, Glyn et al.Journal of general virology. 2009, Vol 90, pp 197-204, issn 0022-1317, 8 p., 1Article

Factors affecting virus plaque confirmation proceduresDAHLING, D. R; SULLIVAN, G; FREYBERG, R. W et al.Journal of virological methods. 1989, Vol 24, Num 1-2, pp 111-122, issn 0166-0934Article

Efficient RGD-independent entry process of coxsackievirus A9ROIVAINEN, M; PIIRAINEN, L; HOVI, T et al.Archives of virology. 1996, Vol 141, Num 10, pp 1909-1919, issn 0304-8608Article

A CASE OF COXSACKIE A9 VIRUS INFECTION WITH ORCHITISWILLEMS WR; HORNIG C; BAUER H et al.1978; J. MED. VIROL.; USA; DA. 1978; VOL. 3; NO 2; PP. 137-140; BIBL. 8 REF.Article

A combined method for rescue of modified enteroviruses by mutagenic primers, long PCR and T7 RNA polymerase-driven in vivo transcriptionHEIKKILÄ, Outi; KAINULAINEN, Markus; SUSI, Petri et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 129-133, issn 0166-0934, 5 p.Article

FREISETZUNG ZELLULAERER ENZYME WAEHREND DER VERMEHRUNG VON COXSACKIEVIRUS A9 IN FL-ZELLEN. II.ABHAENGIGKEIT DER ENZYMFREISETZUNG VON ZELLDICHTE, VIRUSKONZENTRATION, PH-WERT UND SERUMGEHALT DES INKUBATIONSMEDIUMS = LIBERATION DE L'ENZYME CELLULAIRE AU COURS DE LA MULTIPLICATION DU COXSACKIEVIRUS A9 EN CELLULES FL. II.INFLUENCE DU NOMBRE DE CELLULES, DE LA CONCENTRATION DE VIRUS, DU PH ET DE LA TENEUR EN SERUM DU MILIEU DE CULTURE SUR CETTE LIBERATIONKLOCKING R; SCHWEIZER H; SPROSSIG M et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 3-4; PP. 353-359; ABS. ANGL.; BIBL. 10REF.Article

A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virionsROIVAINEN, Merja; ALAKULPPI, Noora; YLIPAASTO, Petri et al.Journal of virological methods. 2005, Vol 130, Num 1-2, pp 108-116, issn 0166-0934, 9 p.Article

Photoinactivation of three viruses by rose bengalLEWIS, A. L; WELLINGS, F. M; MARTIN, D. F et al.Journal of environmental science and health. Part A, Environmental science and engineering. 1988, Vol 23, Num 2, pp 127-137, issn 0360-1226Article

STUDIES ON THE INTERACTION BETWEEN COXSACKIEVIRUS A9 AND HELA CELLS. I. PLAQUE-FORMING ABILITY OF COXSACKIEVIRUS A9 IN HELA CELL CULTURES.MATSUMOTO M; NAKANO M; NISHIKAWA F et al.1976; JAP. J. MED. SCI. BIOL.; JAP.; DA. 1976; VOL. 29; NO 2; PP. 67-76; BIBL. 15 REF.Article

A novel one-step oxidation of terminal epoxides to allylic aldehydesWILLIS, C. L.Tetrahedron letters. 1987, Vol 28, Num 19, pp 2175-2178, issn 0040-4039Article

The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classificationKI HA CHANG; AUVINEN, P; HYYPIA, T et al.Journal of general virology. 1989, Vol 70, Num 12, pp 3269-3280, issn 0022-1317Article

CONSTRUCTION OF VIABLE MOUSE-HUMAN HYBRID CELLS BY NUCLEAR TRANSPLANTATIONHIGHTOWER MJ; LUCAS JJ.1980; J. CELL. PHYSIOL.; ISSN 0021-9541; USA; DA. 1980; VOL. 105; NO 1; PP. 93-103; BIBL. 26 REF.Article

ETUDE DU VACCIN INACTIVE ASSOCIE CONTRE LES COXSACKIEVIRUS A9 ET B1 ET ECHOVIRUS 6BIERNACKI M; JABLONSKI L.1974; MED. DOSW. MIKROBIOL.; POLSKA; DA. 1974; VOL. 26; NO 4; PP. 339-350; ABS. RUSSE ANGL.; BIBL. 6REF.Article

PINOCYTOTIC UPTAKE AND INTRALYSOSOMAL CRYSTAL FORMATION OF COXSACKIEVIRUS A9 IN MONKEY KIDNEY CELLS. AN ELECTRON MICROSCOPIC AUTORADIOGRAPHIC STUDY = ABSORPTION PAR PINOCYTOSE ET FORMATION DE CRISTAUX A L'INTERIEUR DE LYSOSOMES DANS LE CAS DU COXSACKIEVIRUS A9 EN CELLULES RENALES DE SINGE. AUTORADIOGRAPHIE ETUDIEE AU MICROSCOPE ELECTRONIQUEHECKER W; MEYER J; BOENI R et al.1974; ARCH. GES. VIRUSFORSCH.; OESTERR.; DA. 1974; VOL. 46; NO 1-2; PP. 167-174; BIBL. 2P.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

SYNTHESIS OF THE LABELED GIBBERELLIN, GA₉-17-¹⁴CJIANN TSYH LIN; HEFTMANN E.1979; J. LABELL. COMPOUNDS RADIOPHARM.; GBR; DA. 1979; VOL. 16; NO 4; PP. 537-545; BIBL. 17 REF.Article

VARIATION IN SUSCEPTIBILITY OF HE LA CELL LINES TO COXSACKIEVIRUS A 9MATSUMOTO M; MUKAI M; TAGAYA I et al.1979; ARCH. VIROL.; AUT; DA. 1979; VOL. 59; NO 3; PP. 213-222; BIBL. 11 REF.Article

COMPLEMENT ACTIVATION DURING SUBSEQUENT STAGES OF CANINE ENDOTOXIN SHOCKAASEN AO; MELLBYE OJ; OHLSSON K et al.1978; SCAND. J. IMMUNOL.; NOR; DA. 1978; VOL. 8; NO 6; PP. 509-513; BIBL. 26 REF.Article

Welche Kältemittel in der Zukunft? = Which refrigerant in the future?DOÊRING, R.Die Kälte und Klimatechnik. 1990, Vol 43, Num 9, pp 472-482, issn 0343-2246, 6 p.Article

Coxsackie A-9 in the etiology of poliomyelitis-like diseasesSANTHANAM, S; CHOUDHURY, D. S.Indian journal of pediatrics. 1985, Vol 52, Num 417, pp 405-408, issn 0019-5456Article

EOSINOPHILE MENINGOMYELITIS = MENINGOMYELITE AVEC EOSINOPHILIEHOFFMANN HG; KOLMEL HW; ALEXANDER M et al.1982; INFECTION; ISSN 0300-8126; DEU; DA. 1982; VOL. 10; NO 1; PP. 28-30; ABS. GER; BIBL. 13 REF.Article

CELL-MEDIATED IMMUNITY IN MOUSE EXPERIMENTAL COXSACKIE A9 VIRUS INFECTIONVOICULESCU C; NEDELCU C; STANCIU L et al.1980; COMP. IMMUNOL. MICROBIOL. INFECT. DIS.; GBR; DA. 1980; VOL. 3; NO 3; PP. 337-343; ABS. FRE; BIBL. 16 REF.Article

Th17 cytokines and mucosal immunityDUBIN, Patricia J; KOLLS, Jay K.Immunological reviews. 2008, Vol 226, pp 160-171, issn 0105-2896, 12 p.Article